Emerging Edge

United Oil & Gas highlights an unrisked NPV10 of about $23 billion at $80 oil, based on 2.4 billion barrels. Risk-adjusted values are lower, but the potential prize is transformational.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch

United Oil & Gas announces a conditional £1 million fundraising to advance its pivotal piston coring programme at the Walton Morant licence in Jamaica — a key step in unlocking a billion-barrel frontier basin.

#UOG #Energy #Energystocks #Investing #StockMarket #Trading #StocksToWatch

Greatland Gold reports a solid September 2025 quarter with higher production, strong sales, and a major cash build, positioning the company well for FY26.

#GGP #Gold #Copper #MiningStocks #Mining #SmallCapStocks #Investing #StockMarketNews

Poolbeg raised £4.7m in June 2025, boosting cash to ~£10m. The company is funded into 2027, giving runway to deliver trial results. Partnerships further cut costs, making Poolbeg one of AIM’s stronger biotechs financially.

#POLB #Biotech #Investing #SmallCaps #AIMStocks #StocksToWatch #Pharma

Reabold Resources has agreed to sell its interest in LNEnergy for a €16 million earn-out, receiving equity in Beacon and no further funding obligations into Colle Santo.

#RBD #OilAndGas #EnergyStocks #Investing #StocksToWatch

ECR Minerals has completed due diligence at the Raglan alluvial gold project in Queensland, confirming nuggety gold, low operating costs, and strong near-term production potential.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing

United Oil & Gas has permits for surface geochemistry and piston coring. An independent study shows that if hydrocarbons are confirmed, Colibri’s chance of success could rise from 19% to 32%, and Oriole’s from 13% to 21%

#UOG #Energy #Energystocks #Investing #StockMarket #Trading #StocksToWatch

Fulcrum Metals closed the sale of its Tully Gold Project in Ontario to Loyalist Exploration. The transaction gives Fulcrum a strategic equity position, immediate cash, and a long-term royalty.

#Gold #MiningStocks #JuniorMining #SmallCapStocks #Investing #StockMarketNews

Poolbeg’s POLB-001 was granted FDA Orphan Drug Designation in May 2025 for cytokine release syndrome, providing regulatory incentives and exclusivity potential. A Phase 2a trial is underway with results expected in 2026.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks

Blue Mountain is a cornerstone project in Queensland where drilling is complete, visible gold has been found, and assays are pending.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing

The Smarter Web Company has announced a £9.7 million institutional placing, alongside a £2.56 million subscription expected to settle early this week.

#SWC $TSWCF #BitcoinTreasury #Bitcoin #StocksToWatch #Trading

Wishbone Gold is expanding its drilling program at the Red Setter project in Western Australia, targeting deeper zones and improving site efficiency.

#WSBN #Gold #MiningStocks #JuniorMining #SmallCapStocks #Investing #StockMarketNews

Richtech Robotics builds robots that are already working in restaurants, hotels, and warehouses. Here’s what they actually do...

#RR $RR #AIRobotics #Investing #Finance #Stocks #Stockmarket #Trading

Poolbeg is preparing to launch Phase 2A trial of POLB-001 for cytokine release syndrome. ACT has been appointed to run the study, with The Christie NHS Trust and other UK centres selected. First-patient dosing is pending, with interim data expected summer 2026.

#POLB #Biotech #Investing #SmallCaps

Orosur Mining has closed a C$20m private placement, bringing in strong institutional support to fund exploration and growth.

Read here: https://polaris.brighterir.com/public/orosur_mining/news/rns/story/w90kl1w

#OMI $OMI #Gold #MiningStocks #JuniorMining #SmallCapStocks #Investing #StockMarketNews

Blue Star Capital confirms that portfolio company SatoshiPay has released its digital assets treasury strategy, now available on both companies’ websites.

Read here: https://irtools.co.uk/96/story/a2a3f5b8-3bb9-4644-929c-f10a8d003d61

#BLU #DigitalAssets #Blockchain #Crypto #CryptoNews #Investing

United Oil & Gas controls the Walton Morant licence offshore Jamaica, holding over 7 billion barrels unrisked, with 2.4 billion barrels independently certified. Colibri and Oriole lead the prospect inventory.

#UOG #Energystocks #Investing #StockMarket #Trading #StocksToWatch

Wishbone Gold raised £4m to expand exploration at its Red Setter project in Western Australia. The company is now preparing for a major drill campaign, and investors are waiting for results.

#WSBN #Gold #MiningStocks #JuniorMining #SmallCapStocks #Investing #StockMarketNews

ECR Minerals plc is an AIM-listed gold explorer with assets across Queensland and Victoria. It’s targeting both near-term production and longer-term discovery.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing

UKOG has raised £3 million at 0.03p per share to fund its UKEn hydrogen projects in Dorset and Yorkshire.

#UKOG #Hydrogen #CleanEnergy #Investing #StocksToWatch

Bezant Resources announced it has sold over 53 million shares in Blackstone Minerals, raising A$3.75 million. Investors reacted positively, sending the stock higher.

#BZT #Gold #MiningStocks #JuniorMining #GoldStocks #SmallCapStocks #Investing #StockMarketNews

City A.M. reports gold is closing in on the $4,000 milestone as political turmoil, Fed cuts, and central bank buying drive demand for the safe-haven metal.

https://www.cityam.com/gold-to-glitter-past-4000-after-year-of-political-jitters/

#Gold #GoldInvesting $Gold #Mining #GoldBullRun #GoldStocks

United Oil & Gas has exited Egypt and resolved legacy issues. It now focuses on two core assets: the Walton Morant licence in Jamaica and the Waddock Cross redevelopment in the UK.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch

Poolbeg Pharma is a London-listed biotech (£26m cap) developing POLB-001 for oncology support care and an oral GLP-1 obesity drug. Using a lean model, it advances drugs to proof-of-concept before out-licensing.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks